IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.337
EU - Europa 8.999
AS - Asia 5.021
SA - Sud America 2.015
AF - Africa 146
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.166
RU - Federazione Russa 3.001
SG - Singapore 2.098
BR - Brasile 1.798
IE - Irlanda 1.597
CN - Cina 1.505
SE - Svezia 1.417
IT - Italia 800
HK - Hong Kong 646
DE - Germania 540
UA - Ucraina 401
FI - Finlandia 302
PL - Polonia 265
VN - Vietnam 254
GB - Regno Unito 226
FR - Francia 136
IN - India 115
CA - Canada 82
AR - Argentina 76
BE - Belgio 76
AT - Austria 58
MX - Messico 55
BD - Bangladesh 49
ZA - Sudafrica 48
ID - Indonesia 45
TR - Turchia 45
IQ - Iraq 38
EC - Ecuador 34
NL - Olanda 34
ES - Italia 32
CZ - Repubblica Ceca 29
PK - Pakistan 28
JP - Giappone 27
MA - Marocco 27
UZ - Uzbekistan 27
CI - Costa d'Avorio 24
CO - Colombia 21
VE - Venezuela 21
PY - Paraguay 19
LT - Lituania 17
AE - Emirati Arabi Uniti 15
CL - Cile 15
AZ - Azerbaigian 13
BO - Bolivia 13
IL - Israele 13
IR - Iran 13
JO - Giordania 12
KE - Kenya 12
KG - Kirghizistan 11
LB - Libano 11
GR - Grecia 10
NZ - Nuova Zelanda 10
PE - Perù 10
NP - Nepal 9
OM - Oman 8
UY - Uruguay 8
EE - Estonia 7
EG - Egitto 7
KZ - Kazakistan 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
LV - Lettonia 6
JM - Giamaica 5
NO - Norvegia 5
PT - Portogallo 5
TN - Tunisia 5
AM - Armenia 4
AO - Angola 4
AU - Australia 4
BY - Bielorussia 4
BZ - Belize 4
HN - Honduras 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
BN - Brunei Darussalam 3
DK - Danimarca 3
EU - Europa 3
GT - Guatemala 3
KW - Kuwait 3
MD - Moldavia 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PH - Filippine 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 25.519
Salva come PNG Salva come JPEG
Città #
Dublin 1.597
Moscow 1.583
Ashburn 1.359
Dallas 1.319
Singapore 1.125
Chandler 1.074
Nyköping 837
Jacksonville 835
Beijing 649
Hong Kong 645
Messina 413
Ann Arbor 253
Los Angeles 247
Princeton 246
Warsaw 246
Medford 223
Cambridge 188
The Dalles 187
Des Moines 178
Munich 167
São Paulo 154
Dearborn 145
Boardman 117
New York 117
Ho Chi Minh City 93
Buffalo 91
Woodbridge 85
Wilmington 81
Houston 79
Jinan 74
Brussels 72
Redondo Beach 66
Helsinki 62
San Mateo 58
Rio de Janeiro 56
Shenyang 54
Belo Horizonte 53
Hanoi 53
Nanjing 53
Brasília 51
Tianjin 51
Turku 50
Seattle 42
Nuremberg 40
Rome 39
Hebei 38
Falls Church 36
Vienna 36
Haikou 35
Pune 35
Frankfurt am Main 33
Brooklyn 31
Zhengzhou 31
Stockholm 30
Catania 28
Jakarta 28
Orem 27
Phoenix 27
Tokyo 27
Chennai 26
Hyderabad 26
Porto Alegre 26
Santa Clara 26
Bremen 25
Curitiba 25
Abidjan 24
Chicago 24
Montreal 24
San Francisco 24
Atlanta 23
Boston 23
Lancaster 23
Brno 22
Dong Ket 22
Tashkent 22
Guangzhou 20
Guarulhos 20
Nanchang 20
Ningbo 20
Amsterdam 19
Campinas 19
Hangzhou 19
Johannesburg 19
London 19
Ottawa 19
Baghdad 18
Denver 18
Düsseldorf 18
Poplar 18
Ankara 16
Mexico City 16
Changsha 15
Lanzhou 15
Norwalk 15
Rosolini 15
Salvador 15
Uberlândia 15
San Jose 14
Avola 13
Baku 13
Totale 16.462
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 340
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 229
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 216
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 210
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 204
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 202
Atrial fibrillation in patients with cirrhosis 191
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 181
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 174
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 172
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 171
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 169
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 167
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 167
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 165
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 164
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 163
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 161
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 157
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 156
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 154
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 154
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 153
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 153
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 153
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 152
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 152
[A glance into the past ... Southern and northern blot: really superseded?] 150
Control of cccDNA function in hepatitis B virus infection. 149
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 148
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 147
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 147
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 145
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 145
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 142
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 141
Erectile dysfunction in compensated liver cirrhosis 141
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 140
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 140
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 139
Clinical virology of hepatitis B virus infection 138
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 138
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 137
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 136
A 2010 update on occult hepatitis B infection. 135
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 133
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 132
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 131
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 131
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 131
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 129
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 128
Mitochondrial DNA is a target of HBV integration 128
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 127
Correlates of total homocysteine plasma concentration in type 2 diabetes 127
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 126
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 126
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 126
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 125
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 125
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 124
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 122
Obesity and liver cancer 122
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 122
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 120
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 120
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 120
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 120
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 120
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 120
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 119
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 119
Disease progression and liver cancer in the ferroportin disease. 119
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 119
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 118
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 118
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 118
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 118
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 117
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 116
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 116
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 116
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 114
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 114
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 114
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 114
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 113
The changing scenario of hepatocellular carcinoma in Italy: an update 113
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 112
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 112
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 112
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 112
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 111
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 111
CHRONIC HEPATITIS IN PATIENTS WITH ACTIVE HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS COMBINED INFECTIONS - A HISTOLOGICAL STUDY 110
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 109
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 109
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 109
Pattern of macrovascular invasion in hepatocellular carcinoma 108
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 108
Totale 13.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 147 60 221 70 180 108 74
2021/20221.639 20 153 48 58 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/20268.813 718 1.237 1.211 1.097 1.285 3.265 0 0 0 0 0 0
Totale 25.987